Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
NHS England
NHS England
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Graphs and graph data science in drug discovery
Life sciences data expert Dr Alexander Jarasch discusses what work being done at the Institut de Recherches Servier can teach us about using modern data technologies for early...
Why smaller CDMOs should enhance their operational efficiency now: a CPHI expert guide
CPHI experts advise smaller CDMO's to invest in supply chain resilience, friend shoring and AI to keep up with the predicted uptick in funding for 2025
CPI collaborates with industry leaders to expedite drug manufacturing via digitisation
Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process
Janssen to adopt Johnson & Johnson brand as the company celebrates 100 years of UK operation
The company's pharmaceutical and medical technology segments will combine under the Johnson & Johnson brand name in the UK
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Hi Tech Manufacturing
£10m research competition to tackle antimicrobial resistance
Move aims to encourage the development of innovative scientific approaches to addressing antimicrobial resistance
Research & Development
Professor Stephen Hawking gives NHS a stark warning
Professor Hawking spoke candidly at a public debate on his experiences as an NHS patient, the trials and tribulations of his physical health conditions and his views on its future
Regulatory
NICE decision sends “stark, negative signal” to UK life sciences
Changes announced by NICE and NHS will limit patient access to potentially life-saving medicines, says CEO of BIA
Regulatory
NHS England publishes authoritative information on biosimilar medicines
Document provides key clinical and non-clinical stakeholders with accessible information on how to support the appropriate use of all biological medicines
Subscribe now